Scientists launch major registry to track elusive neuroendocrine tumors
NCT ID NCT02270567
Summary
This study is creating a registry to collect information and blood samples from people with neuroendocrine tumors (NETs). The main goal is to learn more about these cancers and to see how well a specific blood test, called NETest, works for diagnosis and tracking the disease over time. It does not test a new treatment but aims to gather knowledge to improve future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wren Laboratories
Branford, Connecticut, 06405, United States
Conditions
Explore the condition pages connected to this study.